León-Rodríguez E, Sosa Sánchez R, Gómez E, Ochoa Sosa C
Servicio de Hemato-oncología, Instituto Nacional de la Nutrición Salvador Zubirán, México D. F.
Rev Invest Clin. 1993 Nov-Dec;45(6):559-64.
During the period of May 1986 through February 1991, nine allogeneic bone marrow transplants (BMT) on eight severe aplastic anemia (SAA) patients were performed at the Instituto Nacional de la Nutrición Salvador Zubirán in Mexico City. Mean age at BMT was 18 years (age interval 12-30); seven were men; all patients had a clinical history of multiple blood transfusions; six individuals were infected at the time of the transplant. The conditioning regimens were: cyclophosphamide (Cy) in three patients; Cy+ total nodal radiation in five; and total nodal radiation only in the second transplant of one patient. Graft versus host disease (GVHD) prophylaxis was attempted with methotrexate plus cyclosporin A (CsA) in six patients, methylprednisolone plus CsA in two, and prednisone + CsA in the patient retransplanted. All procedures were carried out under single reverse isolation without gut decontamination. Seven of the nine procedures grafted (two cases died on days +8 and +25 due to infection). In the surviving, the median time for reaching > 1.0 white blood cells x 10(9)/L was 22 days (time interval 11-31); > 0.5 neutrophils x 10(9)/L in 27 days (time interval 15-42) and the same lapse to reach > 50 platelets x 10(9)/L. Length of hospital stay was 42 days (time interval 15-61). Acute GVHD was seen in one of the seven patients surviving the period of bone marrow aplasia (14%). Of six long term survivors (including one patient with a second transplant) chronic GVHD was present in four (67%): chronic GVHD was fatal in one individual but was well controlled in three.(ABSTRACT TRUNCATED AT 250 WORDS)
1986年5月至1991年2月期间,墨西哥城萨尔瓦多·苏比拉án国家营养研究所对8例重型再生障碍性贫血(SAA)患者进行了9次异基因骨髓移植(BMT)。BMT时的平均年龄为18岁(年龄范围12 - 30岁);7例为男性;所有患者均有多次输血的临床病史;6例患者在移植时已感染。预处理方案为:3例患者采用环磷酰胺(Cy);5例采用Cy + 全身淋巴结照射;1例患者的第二次移植仅采用全身淋巴结照射。6例患者尝试用甲氨蝶呤加环孢素A(CsA)预防移植物抗宿主病(GVHD),2例采用甲泼尼龙加CsA,再次移植的患者采用泼尼松 + CsA。所有操作均在单人反向隔离且未进行肠道去污的情况下进行。9例手术中有7例移植成功(2例分别在第8天和第25天因感染死亡)。存活患者中,白细胞计数>1.0×10⁹/L的中位时间为22天(时间范围11 - 31天);中性粒细胞计数>0.5×10⁹/L的时间为27天(时间范围15 - 42天),达到血小板计数>50×10⁹/L的时间相同。住院时间为42天(时间范围15 - 61天)。在骨髓抑制期存活的7例患者中有1例发生急性GVHD(14%)。6例长期存活者(包括1例接受第二次移植的患者)中有4例(67%)出现慢性GVHD:慢性GVHD导致1例患者死亡,但在3例患者中得到良好控制。(摘要截选至250字)